Silverleafe Capital Partners LLC Acquires New Stake in Core Scientific, Inc. $CORZ

Key Points

• Silverleafe Capital Partners LLC bought a new position of 72,950 shares of Core Scientific (NASDAQ:CORZ) in Q4, valued at approximately $1.062 million.
• Core Scientific reported quarterly EPS of $0.42, beating estimates (‑$0.27), while revenue of $79.76 million missed forecasts and declined 16% year‑over‑year.
• Analyst views are mixed but tilted positive: MarketBeat shows a consensus rating of "Moderate Buy" with an average target price of $24.84, though individual ratings range from Strong Buy to Sell.

Silverleafe Capital Partners LLC bought a new position in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 72,950 shares of the company's stock, valued at approximately $1,062,000.

A number of other large investors have also modified their holdings of the business. Allworth Financial LP raised its position in shares of Core Scientific by 206.5% in the third quarter. Allworth Financial LP now owns 1,410 shares of the company's stock valued at $25,000 after buying an additional 950 shares during the last quarter. Osaic Holdings Inc. grew its stake in Core Scientific by 112.1% during the 2nd quarter. Osaic Holdings Inc. now owns 2,017 shares of the company's stock valued at $34,000 after acquiring an additional 1,066 shares in the last quarter. Advisors Asset Management Inc. grew its stake in Core Scientific by 68.3% during the 2nd quarter. Advisors Asset Management Inc. now owns 2,690 shares of the company's stock valued at $46,000 after acquiring an additional 1,092 shares in the last quarter. PNC Financial Services Group Inc. grew its stake in Core Scientific by 396.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 3,731 shares of the company's stock valued at $64,000 after acquiring an additional 2,980 shares in the last quarter. Finally, Russell Investments Group Ltd. raised its holdings in Core Scientific by 61.9% in the 2nd quarter. Russell Investments Group Ltd. now owns 3,942 shares of the company's stock valued at $67,000 after acquiring an additional 1,507 shares during the last quarter.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Cantor Fitzgerald lowered their target price on Core Scientific from $26.00 to $25.00 and set an "overweight" rating on the stock in a report on Tuesday, March 3rd. Wall Street Zen raised Core Scientific to a "sell" rating in a report on Saturday, March 14th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Core Scientific in a research report on Wednesday, January 21st. Citizens Jmp upgraded Core Scientific from a "market perform" rating to an "outperform" rating and set a $30.00 target price for the company in a report on Thursday, December 18th. Finally, Needham & Company LLC raised Core Scientific from a "hold" rating to a "buy" rating and set a $23.00 target price for the company in a research note on Tuesday, March 3rd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $24.84.

Core Scientific Price Performance

Shares of NASDAQ CORZ opened at $17.05 on Thursday. The company has a 50 day simple moving average of $17.29 and a 200-day simple moving average of $17.19. The company has a market capitalization of $5.38 billion, a P/E ratio of 14.57 and a beta of 6.87. Core Scientific, Inc. has a 1 year low of $6.20 and a 1 year high of $23.63.

Core Scientific (NASDAQ:CORZ - Get Free Report) last released its quarterly earnings data on Monday, March 2nd. The company reported $0.42 EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.69. The business had revenue of $79.76 million during the quarter, compared to analyst estimates of $118.45 million. The company's revenue was down 16.0% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.69) earnings per share. As a group, research analysts expect that Core Scientific, Inc. will post 0.52 EPS for the current year.

About Core Scientific

Core Scientific, Inc NASDAQ: CORZ is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific's service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.

Want to see what other hedge funds are holding CORZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Scientific, Inc. (NASDAQ:CORZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.